Related Experiment Video
Updated: Mar 3, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Protein kinase C as a tumor suppressor
1Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093-0721, USA.
Protein kinase C (PKC) was thought to promote cancer, but new research shows it acts as a tumor suppressor. Cancer mutations often disable PKC, while enhanced activity links to diseases like Alzheimer's.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Protein kinase C (PKC) has been historically viewed as an oncoprotein due to its activation by phorbol esters.
- Decades of clinical trials targeting PKC in cancer have yielded unsuccessful results, sometimes worsening patient outcomes.
Purpose of the Study:
- To re-evaluate the role of PKC in cancer by investigating cancer-associated mutations.
- To explore the contrasting roles of PKC activity in cancer versus degenerative diseases.
Main Methods:
- Review of existing literature on PKC function, cancer mutations, and clinical trial data.
- Analysis of recent findings on PKC isozyme activity and disease association.
Main Results:
- Cancer-associated mutations in PKC are predominantly loss-of-function (LOF), suggesting a tumor-suppressive role.
- Germline mutations that increase PKC activity are linked to neurodegenerative conditions like Alzheimer's disease.
Conclusions:
- PKC family members generally function as suppressors of survival signaling, challenging the oncoprotein hypothesis.
- Understanding the precise regulation of PKC activity is crucial for therapeutic development in cancer and other diseases.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...